Patents by Inventor Masao Daimon

Masao Daimon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSTIC AGENT FOR ISCHEMIC HEART DISEASE RISK GROUP
    Publication number: 20130310321
    Abstract: The present invention relates to a diagnostic agent for an ischemic heart disease risk group comprising an anti-brain-derived neurotrophic factor antibody as an effective ingredient, to an assay method for an ischemic heart disease risk group performed by measuring a brain-derived neurotrophic factor concentration in blood, and to a suppressive/preventive drug for ischemic heart disease, particularly for post-infarction myocardial remodeling, comprising a brain-derived neurotrophic factor.
    Type: Application
    Filed: July 29, 2013
    Publication date: November 21, 2013
    Applicants: DAIICHI PURE CHEMICALS CO., LTD.
    Inventors: Masao DAIMON, Tohru Minamino, Kenji Hashimoto, Issei Komuro
  • DIAGNOSTIC AGENT FOR ISCHEMIC HEART DISEASE RISK GROUP
    Publication number: 20120122777
    Abstract: The present invention relates to a diagnostic agent for an ischemic heart disease risk group comprising an anti-brain-derived neurotrophic factor antibody as an effective ingredient, to an assay method for an ischemic heart disease risk group performed by measuring a brain-derived neurotrophic factor concentration in blood, and to a suppressive/preventive drug for ischemic heart disease, particularly for post-infarction myocardial remodeling, comprising a brain-derived neurotrophic factor.
    Type: Application
    Filed: June 16, 2011
    Publication date: May 17, 2012
    Applicants: Masao Daimon, DAIICHI PURE CHEMICALS CO., LTD.
    Inventors: Masao DAIMON, Tohru MINAMINO, Kenji HASHIMOTO, Issei KOMURO
  • Diagnostic Agent For Ischemic Heart Disease Risk Group
    Publication number: 20080146498
    Abstract: The present invention relates to a diagnostic agent for an ischemic heart disease risk group comprising an anti-brain-derived neurotrophic factor antibody as an effective ingredient, to an assay method for an ischemic heart disease risk group performed by measuring a brain-derived neurotrophic factor concentration in blood, and to a suppressive/preventive drug for ischemic heart disease, particularly for post-infarction myocardial remodeling, comprising a brain-derived neurotrophic factor.
    Type: Application
    Filed: March 2, 2005
    Publication date: June 19, 2008
    Applicants: Daiichi Pure Chemicals Co., Ltd.
    Inventors: Masao Daimon, Tohru Minamino, Kenji Hashimoto, Issei Komuro